Zhongtai: The implementation of the tenth batch of centralized procurement is expected to accelerate the clearance of generic drugs. Commercial insurance is an important incremental logic in the pharmaceutical Sector.

It is recommended to keep a close eye on the progress and implementation of commercial insurance, as improvements in the payment sector are expected to bring about a significant market trend in the Pharmaceutical Sector, with opportunities for recovery and reversal in hospital pharmaceuticals, diagnostics, and Medical Devices.

Zhitong FinanceDec 16 14:45

Express News | The amount repurchased in A-shares this year has approached 162.3 billion yuan.

BreakingsDec 16 12:36

Express News | Overview of Share Buybacks in A-shares: 2 companies disclose buyback progress.

BreakingsDec 16 07:35

WuXi AppTec Co. Announces Board of Directors Changes

TipRanksDec 12 18:39

WUXI APPTEC (02359.HK) plans to nominate Leng Xuesong as an independent non-executive Director candidate.

On December 12, Gelonghui reported that WUXI APPTEC (02359.HK) announced that according to the relevant provisions of the "Administrative Measures for Independent Directors of Listed Companies", the term of office for independent directors of listed companies shall not exceed six years. Since independent non-executive director Feng Dai's term as independent director of the company will reach six years, he can no longer serve as the company's independent director. Accordingly, Feng Dai has notified the Board of Directors that he will resign from the position of independent non-executive director of the third Board of Directors and from the role of chairman or member of certain board committees. After reviewing the relevant recommendations and qualifications, the Board of Directors has proposed to nominate Leng Xuesong as the candidate for independent non-executive director of the third Board of Directors.

Gelonghui FinanceDec 12 18:32

The tenth batch of Pharmaceutical centralized procurement in the mainland is about to begin bidding, with 62 types of Pharmaceuticals included in the national procurement.

The national Pharmaceutical procurement declaration information public conference will be held today (12th) in Shanghai, signaling the upcoming opening of bids for the tenth national Pharmaceutical concentrated procurement. This national procurement includes 62 types of Pharmaceuticals. Since the pilot for concentrated Pharmaceutical procurement launched in 2018 in four direct-controlled municipalities and seven sub-provincial cities, the process has gradually normalized. In recent years, it has generally occurred twice a year, while the tenth batch of procurement is the only national procurement for 2024. This national procurement includes 62 types of Pharmaceuticals, covering various disease areas such as cardiovascular and cerebrovascular, digestive, tumors, and metabolism, with more than half being injections sold through Hospital channels. The procurement cycle for each variety is determined by the selection results.

AASTOCKSDec 12 10:32